Citation: | Jie GONG, Xiaofei XU. Research progress of MR functional imaging in primary hepatic caminoma[J]. Journal of Molecular Imaging, 2018, 41(4): 461-464. doi: 10.12122/j.issn.1674-4500.2018.04.10 |
[1] |
Parkin DM. Global cancer statistics in the year 2000[J]. Lancet oncol, 2001, 2(9): 533-43 doi: 10.1016/S1470-2045(01)00486-7
|
[2] |
中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 中华消化外科杂志, 2017, 16(7): 635-47 doi: 10.3760/cma.j.issn.1673-9752.2017.07.001
|
[3] |
蒙秋华, 龙莉玲, 黄仲奎, 等. 原发性肝癌的MRI诊断价值[J]. 实用放射学杂志, 2006, 22(1): 45-9 doi: 10.3969/j.issn.1002-1671.2006.01.013
|
[4] |
Ebara M, Ohto M, Watanabe Y, et al. Diagnosis of small hepatocellular carcinoma: correlation of Mr imaging and tumor histologic studies[J]. Radiology, 1986, 159(2): 371-7 doi: 10.1148/radiology.159.2.3008213
|
[5] |
边 杰, 王之章. 原发性肝癌的磁共振成像及病理对照研究[J]. 中华放射学杂志, 1993, 40(2): 86-90
|
[6] |
周康荣, 陈祖望. 体部磁共振成像[M]. 上海: 上海医科大学出版社, 2000: 1005-201.
|
[7] |
Pang EH, Harris AC, Chang SD. Approach to the solitary liver lesion: imaging and when to biopsy[J]. Canad Associat Radiol J, 2016, 67(2): 130-48 doi: 10.1016/j.carj.2015.07.005
|
[8] |
郭启勇, 辛 军, 张 新, 等. MRI水扩散加权成像分子机理研究进展[J]. 中国临床医学影像杂志, 2013, 24(7): 496-500 doi: 10.3969/j.issn.1008-1062.2013.07.014
|
[9] |
曾洪武, 王培军. 磁共振扩散加权与弥散张量成像原理分析及比较[J]. 中国医学影像技术, 2005, 21(12): 1945-7 doi: 10.3321/j.issn:1003-3289.2005.12.042
|
[10] |
Tokgoz O, Unlu E, Unal I, et al. Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver[J]. Afr Health Sci, 2016, 16(1): 227-33 doi: 10.4314/ahs.v16i1.30
|
[11] |
Li R, Wu G, Wang R. Application values of 3.0T magnetic resonance diffusion weighted imaging for distinguishing liver malignant tumors and benign lesions[J]. Oncol Lett, 2018, 15(2): 2091-6
|
[12] |
胡伟卓, 刘忠虎, 秦红娟, 等. 不同分化程度的原发性肝癌MRI初步临床研究[J]. 现代生物医学进展, 2017, 17(26): 5074-8
|
[13] |
Woo S, Lee JM, Yoon JH, et al. Intravoxel incoherent motion diffusion-weighted Mr imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade[J]. Radiology, 2014, 270(3): 758-67 doi: 10.1148/radiol.13130444
|
[14] |
Catalano OA, Choy G, Zhu A, et al. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted Mr imaging[J]. Radiology, 2010, 254(1): 154-62 doi: 10.1148/radiol.09090304
|
[15] |
沈继明, 张学琴, 梁宏伟, 等. DWI、T2WI及MR动态增强扫描成像对不同分化小肝癌定量研究[J]. 中国CT和MRI杂志, 2016, 13(2): 75-7 doi: 10.3969/j.issn.1672-5131.2016.02.024
|
[16] |
Petra GK, Eric J. Diffusion weighted imaging in the liver[J]. World J Gastroenterol, 2010, 16(13): 1567-76 doi: 10.3748/wjg.v16.i13.1567
|
[17] |
Tajima T, Honda H, Taguchi K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation[J]. Am J Roentgenol, 2002, 178(4): 885-97 doi: 10.2214/ajr.178.4.1780885
|
[18] |
马文婷. CDT-VIBE GD-EOB-DTPA增强MR诊断小肝癌的临床应用研究[D]. 兰州: 兰州大学, 2017.
|
[19] |
殷婷婷, 顾 红, 杨儒牛, 等. MRI联合应用DWI和DCE扫描序列在发现肝癌切除术后肝内复发微小癌灶的价值分析[J]. 实用肝脏病杂志, 2017, 20(5): 625-6 doi: 10.3969/j.issn.1672-5069.2017.05.036
|
[20] |
Powerski MJ, Scheurig-Münkler C, Hamm B, et al. Impaired hepatic Gd-EOB-DTPA enhancement after radioembolisation of liver malignancies[J]. J Med Imag Radiat Oncol, 2014, 58(4): 472-80
|
[21] |
Li L, Gao F, Jiang W, et al. Folic acid-conjugated superparamagnetic Iron oxide nanoparticles for tumor-targeting Mr imaging[J]. Drug Deliv, 2016, 23(5): 1726-33
|
[22] |
Moon M, Thomas RG, Heo SU, et al. A hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 contrast agent for liver magnetic resonance imaging[J]. Mol Imaging Biol, 2015, 17(4): 497-503 doi: 10.1007/s11307-014-0819-z
|
[23] |
Liang J, Zhang X, Miao Y, et al. Lipid-coated Iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma[J]. Int J Nanomedicine, 2017, 12(8): 2033-44
|
[24] |
Capurro M, Wanless IR, Sherman M, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma[J]. Gastroenterology, 2003, 125(1): 89-97 doi: 10.1016/S0016-5085(03)00689-9
|
[25] |
Nakatsura T, Yoshitake Y, Senju S, et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker[J]. Biochem Biophys Res Commun, 2003, 306(1): 16-25 doi: 10.1016/S0006-291X(03)00908-2
|
[26] |
Park JO, Stephen Z, Sun C, et al. Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles[J]. Mol Imaging, 2011, 10(1): 69-77
|
[27] |
邝 菲, 王 飞. 氢质子磁共振波谱(1H-MRS)技术应用[J]. 医学影像学杂志, 2007, 17(8): 871-4 doi: 10.3969/j.issn.1006-9011.2007.08.034
|
[28] |
Zhang L, Zhao X, Ouyang H, et al. Diagnostic value of 3.0T (1)H MRS with choline-containing compounds ratio (?CCC) in primary malignant hepatic tumors[J]. Cancer Imaging, 2016, 16(1): 25-9 doi: 10.1186/s40644-016-0082-4
|
[29] |
王德清, 赵振华, 王伯胤, 等. 3.0T1H-MRS在原发性肝癌及肝脏非肝细胞癌肿瘤中的诊断价值[C]//浙江省医学会放射学学术年会, 2015: 1-4.
|
[30] |
Wang JX, Merritt ME, Sherry D, et al. A general chemical shift decomposition method for hyperpolarized (13) C metabolite magnetic resonance imaging[J]. Magn Reson Chem, 2016, 54(8): 665-73 doi: 10.1002/mrc.v54.8
|
[31] |
Darpolor MM, Kaplan DE, Pedersen PL, et al. Human hepatocellular carcinoma metabolism: imaging by hyperpolarized 13C magnetic resonance spectroscopy[J]. J Liver Dis Transplant, 2012, 1(1): 32-9
|
[32] |
孟 俊. T2*加权与T1加权灌注成像对肝细胞癌的对比研究[D]. 川北医学院, 2013.
|
[33] |
刘灿丽, 王家平, 袁曙光, 等. 磁共振灌注成像在原发性肝癌中的临床应用[J]. 放射学实践, 2010, 25(5): 519-21 doi: 10.3969/j.issn.1000-0313.2010.05.014
|
[34] |
Li XH, Liang Q, Zhuang L, et al. Preliminary study of Mr diffusion tensor imaging of the liver for the diagnosis of hepatocellular carcinoma[J]. PLoS One, 2015, 10(8): e0135568-74 doi: 10.1371/journal.pone.0135568
|
[35] |
Erturk SM, Ichikawa T, Kaya E, et al. Diffusion tensor imaging of cysts, hemangiomas, and metastases of the liver[J]. Acta radiol, 2014, 55(6): 654-60 doi: 10.1177/0284185113504916
|
[36] |
陈丽华, 刘爱连, 宋清伟, 等. 磁共振扩散张量成像鉴别诊断肝内胆管细胞癌与肝细胞癌[J]. 中国医学影像技术, 2017, 33(7): 993-7
|
[37] |
周卫兵. 磁共振扩散张量成像对肝脏病变诊断的初步研究[D]. 南昌: 南昌大学, 2011.
|